PT Suparma Tbk (SPMA.JK)
IDR 300.0
(-0.66%)
IDR 300.0
(-0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 686.66 Billion | 919.2 Billion | 791.8 Billion | 461.15 Billion | 112.95 Billion | 224.28 Billion |
| Net Income | 178.65 Billion | 336.13 Billion | 294.32 Billion | 162.52 Billion | 131 Billion | 82.23 Billion |
| Depreciation & Amortization | 111.02 Billion | 104.65 Billion | 91.28 Billion | 93.4 Billion | 89.11 Billion | 87.38 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 396.98 Billion | 478.41 Billion | 406.19 Billion | 205.22 Billion | 71.06 Billion | 229.43 Billion |
| Investing Cash Flow | -23.34 Billion | -68.06 Billion | -63.33 Billion | -285.19 Billion | 49.9 Billion | -51.46 Billion |
| Investments in PPE | -31.71 Billion | -57.05 Billion | -47.03 Billion | -297.93 Billion | -132.57 Billion | -50.97 Billion |
| Acquisitions | 200 Million | 11.01 Billion | 16.29 Billion | 14.53 Billion | 150.37 Billion | 3.66 Billion |
| Investment purchases | -4.83 Billion | -12.11 Billion | -16.68 Billion | -1.78 Billion | -1.11 Billion | -781.68 Million |
| Sales/Maturities of investments | 13.01 Billion | 1.1 Billion | 389.87 Million | 1.78 Billion | 529.8 Million | - |
| Other Investing Activities | 8.17 Billion | -11.01 Billion | -16.29 Billion | -1.78 Billion | 32.69 Billion | -3.37 Billion |
| Financing Cash Flow | -649.66 Billion | -754.9 Billion | -644.56 Billion | -272.35 Billion | -193.36 Billion | -54.29 Billion |
| Debt repayment | -571.88 Billion | -3538.53 Billion | -3773.96 Billion | -255.53 Billion | -193.36 Billion | -54.29 Billion |
| Dividends payments | - | - | -31.63 Billion | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -32.78 Billion | 2783.63 Billion | 3161.03 Billion | -16.81 Billion | -109.8 Billion | -8.47 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 300.14 Billion | 197.49 Billion | 111.72 Billion | 207.41 Billion | 240.38 Billion | 149.85 Billion |
| Cash at end of period | 311.95 Billion | 300.14 Billion | 197.49 Billion | 111.72 Billion | 207.41 Billion | 240.38 Billion |
| Capital Expenditure | -31.71 Billion | -57.05 Billion | -47.03 Billion | -297.93 Billion | -132.57 Billion | -50.97 Billion |
| Effect of forex changes on cash | -1.84 Billion | 6.41 Billion | 1.86 Billion | 720.67 Million | -2.46 Billion | 1.31 Billion |
| Net cash flow / Change in cash | 11.81 Billion | 102.65 Billion | 85.76 Billion | -95.69 Billion | -32.96 Billion | 90.52 Billion |
| Free Cash Flow | 654.95 Billion | 862.15 Billion | 744.76 Billion | 163.22 Billion | -19.62 Billion | 173.31 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 65.86 Billion | 26.41 Billion | 22.58 Billion | 178.65 Billion | 34.92 Billion | 24.33 Billion |
| Depreciation & Amortization | 28.55 Billion | 28.33 Billion | 28.05 Billion | 111.02 Billion | 27.72 Billion | 27.93 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 23.55 Billion | 158.65 Billion | 161.71 Billion | 396.98 Billion | 164.66 Billion | 156.36 Billion |
| Investing Cash Flow | -3.64 Billion | -19 Billion | -13.05 Billion | -23.34 Billion | 6.06 Billion | -5.9 Billion |
| Investments in PPE | 1.67 Billion | -18.28 Billion | -13.42 Billion | -31.71 Billion | -1.15 Billion | -8.51 Billion |
| Acquisitions | - | - | - | 200 Million | 200 Million | -2.61 Billion |
| Investment purchases | -5.31 Billion | -721.38 Million | -1.5 Billion | -4.83 Billion | -655.53 Million | -934.47 Million |
| Sales/Maturities of investments | - | - | 1.87 Billion | 13.01 Billion | 7.68 Billion | 3.54 Billion |
| Other Investing Activities | - | -721.38 Million | 374.58 Million | 8.17 Billion | 7.02 Billion | 2.61 Billion |
| Financing Cash Flow | -293.65 Billion | -61.02 Billion | -191.21 Billion | -649.66 Billion | -237.16 Billion | -78 Billion |
| Debt repayment | -249.87 Billion | -51.17 Billion | -177.06 Billion | -571.88 Billion | -221.46 Billion | -772.36 Billion |
| Dividends payments | -37.75 Billion | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6.01 Billion | -1.24 Billion | -37.04 Billion | -32.78 Billion | -1.36 Billion | 694.36 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 340.07 Billion | 263.26 Billion | 311.95 Billion | 300.14 Billion | 317.01 Billion | 191.77 Billion |
| Cash at end of period | 166.71 Billion | 340.07 Billion | 263.26 Billion | 311.95 Billion | 311.95 Billion | 317.01 Billion |
| Capital Expenditure | 1.67 Billion | -18.28 Billion | -13.42 Billion | -31.71 Billion | -1.15 Billion | -8.51 Billion |
| Effect of forex changes on cash | - | 97.15 Million | -670.11 Million | -1.84 Billion | -1.27 Billion | 506.98 Million |
| Net cash flow / Change in cash | -173.35 Billion | 76.8 Billion | -48.69 Billion | 11.81 Billion | -5.06 Billion | 125.24 Billion |
| Free Cash Flow | 119.65 Billion | 138.45 Billion | 142.81 Billion | 654.95 Billion | 226.15 Billion | 200.12 Billion |
CSNVY
271560
091700
CDRO
SSIA
020000